DNAVisit leverages advanced technologies to enhance genetic counseling and improve patient outcomes through its innovative Clinical Delivery Platform. This platform integrates various digital health solutions, including HIPAA-compliant phone, video, and digital chat options, allowing seamless communication between genetic counselors, pharmacists, and patients. The system is designed to optimize the genetic testing journey by incorporating smart scheduling and AI-powered medical records review, ensuring that healthcare providers can efficiently manage patient interactions and access necessary information.

Additionally, DNAVisit focuses on enhancing the capabilities of healthcare organizations and biopharmaceutical companies by offering tools for risk stratification and patient recruitment. Their platform facilitates the integration of digital health questionnaires and provides access to a vast health exchange covering over 300 million individuals, enabling the identification of relevant patient insights. By maximizing the clinical value of genomics, DNAVisit supports ongoing monitoring and care plans, ensuring that patients receive timely access to genetic counselors and pharmacists as needed.

United States

Develop artificial intelligence that is utilized to aid and augment certified genetic counselors and pharmacists, during pre-test, post-test and support services.

DNAVisit

Company Details